Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Anorexia 6Cachexia 5Weight Loss 3Breast Neoplasms 3Neoplasms 2Lung Neoplasms 2Body Weight 2Squamous Cell Carcinoma of Head and Neck 1Prosthesis Failure 1Pancreatic Neoplasms 1Nutrition Disorders 1Menorrhagia 1Liver Neoplasms 1Leiomyoma 1Hot Flashes 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Body Weight Changes 1

Interventions

Oxandrolone 1Megestrol Acetate 1Immunoenzyme Techniques 1Early Intervention, Educational 1Cyproheptadine 1Creatine 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Body Weight Changes × Megestrol Acetate × Clear all
NCT00070148 2021-09-09

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer

Wake Forest University Health Sciences

Phase 3 Completed
155 enrolled

Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡